Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Overactive Bladder
Related studies linked through entity extraction aliases.
Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up
- Status
- COMPLETED
- Phase
- N/A
Bacterial Genomic Sequencing in Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE2
A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014)
- Status
- COMPLETED
- Phase
- PHASE1
Premarin Versus Toviaz for Treatment of Overactive Bladder
- Status
- UNKNOWN
- Phase
- PHASE4
Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
- Status
- TERMINATED
- Phase
- PHASE4
Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE4
Painless Laser Therapy for Overactive Bladder
- Status
- UNKNOWN
- Phase
- NA
An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics
- Status
- TERMINATED
- Phase
- PHASE1
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)
- Status
- COMPLETED
- Phase
- PHASE4
Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder
- Status
- COMPLETED
- Phase
- NA
Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)
- Status
- TERMINATED
- Phase
- PHASE1
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
- Status
- COMPLETED
- Phase
- NA
Post Marketing Survey of Vesicare in Japan
- Status
- COMPLETED
- Phase
- N/A
Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin
- Status
- COMPLETED
- Phase
- N/A
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
- Status
- UNKNOWN
- Phase
- PHASE4